191 related articles for article (PubMed ID: 18769883)
41. Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.
Gupta AK; Pinsky P; Rall C; Mutch M; Dry S; Seligson D; Schoen RE
Gastrointest Endosc; 2009 Aug; 70(2):322-30. PubMed ID: 19539919
[TBL] [Abstract][Full Text] [Related]
42. A multicenter study of prevalence and risk factors for aberrant crypt foci.
Mutch MG; Schoen RE; Fleshman JW; Rall CJ; Dry S; Seligson D; Charabaty A; Chia D; Umar A; Viner J; Hawk E; Pinsky PF
Clin Gastroenterol Hepatol; 2009 May; 7(5):568-74. PubMed ID: 19418605
[TBL] [Abstract][Full Text] [Related]
43. Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups.
Ghosh S; Gupta B; Verma P; Vishnubathla S; Pal S; Dash NR; Gupta SD; Das P
Intest Res; 2018 Jan; 16(1):116-125. PubMed ID: 29422806
[TBL] [Abstract][Full Text] [Related]
44. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.
Roncucci L; Pedroni M; Vaccina F; Benatti P; Marzona L; De Pol A
Cell Prolif; 2000 Feb; 33(1):1-18. PubMed ID: 10741640
[TBL] [Abstract][Full Text] [Related]
45. An evaluation of colorectal endoscopic mucosal resection using high-magnification chromoscopic colonoscopy: a prospective study of 1000 colonoscopies.
Hurlstone DP; Cross SS; Drew K; Adam I; Shorthouse AJ; Brown S; Sanders DS; Lobo AJ
Endoscopy; 2004 Jun; 36(6):491-8. PubMed ID: 15202044
[TBL] [Abstract][Full Text] [Related]
46. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression.
Thorup I
Carcinogenesis; 1997 Mar; 18(3):465-72. PubMed ID: 9067543
[TBL] [Abstract][Full Text] [Related]
47. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
[TBL] [Abstract][Full Text] [Related]
48. Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence.
Xu MH; Deng CS; Zhu YQ; Lin J
World J Gastroenterol; 2003 Jun; 9(6):1246-50. PubMed ID: 12800233
[TBL] [Abstract][Full Text] [Related]
49. Colonic aberrant crypts may originate from impaired fissioning: relevance to increased risk of neoplasia.
Kristt D; Bryan K; Gal R
Hum Pathol; 1999 Dec; 30(12):1449-58. PubMed ID: 10667423
[TBL] [Abstract][Full Text] [Related]
50. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
Das P; Jain D; Vaiphei K; Wig JD
Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
[TBL] [Abstract][Full Text] [Related]
51. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
52. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
[TBL] [Abstract][Full Text] [Related]
53. Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.
Drew DA; Mo A; Grady JJ; Stevens RG; Levine JB; Brenner BM; Anderson JC; Forouhar F; O'Brien MJ; Devers TJ; Rosenberg DW
Mol Cancer Res; 2018 Mar; 16(3):486-495. PubMed ID: 29222172
[TBL] [Abstract][Full Text] [Related]
54. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
[TBL] [Abstract][Full Text] [Related]
55. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.
Carroll RE; Benya RV; Turgeon DK; Vareed S; Neuman M; Rodriguez L; Kakarala M; Carpenter PM; McLaren C; Meyskens FL; Brenner DE
Cancer Prev Res (Phila); 2011 Mar; 4(3):354-64. PubMed ID: 21372035
[TBL] [Abstract][Full Text] [Related]
56. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
Takayama T; Miyanishi K; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Kogawa T; Abe T; Niitsu Y
Clin Gastroenterol Hepatol; 2005 Jul; 3(7 Suppl 1):S42-5. PubMed ID: 16012995
[TBL] [Abstract][Full Text] [Related]
57. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.
Kearney KE; Pretlow TG; Pretlow TP
Int J Cancer; 2009 Jul; 125(1):249-52. PubMed ID: 19358283
[TBL] [Abstract][Full Text] [Related]
59. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
[TBL] [Abstract][Full Text] [Related]
60. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
